(FCN) FTI Consulting - Overview
Stock: Business Advisory, Restructuring, Forensic, Economic, Technology, Communications
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 24.8% |
| Relative Tail Risk | -11.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.32 |
| Alpha | -16.02 |
| Character TTM | |
|---|---|
| Beta | 0.328 |
| Beta Downside | -0.019 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.34% |
| CAGR/Max DD | 0.09 |
Description: FCN FTI Consulting January 08, 2026
FTI Consulting, Inc. (NYSE:FCN) delivers global business-advisory services across five segments-Corporate Finance & Restructuring, Forensic & Litigation Consulting, Economic Consulting, Technology, and Strategic Communications-helping clients manage change, mitigate risk, and resolve disputes.
The Corporate Finance & Restructuring unit focuses on transformation, transaction advisory, and turnaround solutions, while the Forensic & Litigation arm provides construction-environmental services, data analytics, health-care investigations, and broader risk-management support.
Economic Consulting offers antitrust, competition, financial economics, and international arbitration expertise; the Technology segment delivers legal-department consulting, e-discovery, and information-governance, privacy, and security services; and Strategic Communications handles corporate reputation, financial communications, and public-affairs initiatives.
FTI serves a wide-ranging client base that includes aerospace & defense, energy (including renewable transition), financial services, healthcare, real estate, and the emerging blockchain & digital-assets space, reflecting its diversified exposure to sectors that are currently benefiting from heightened ESG scrutiny and digital-transformation spending.
Key recent metrics: FY 2023 revenue reached approximately $2.1 billion, with an adjusted EBITDA margin near 12%; forensic services grew ~8% YoY, driven by increased litigation around ESG and data-privacy; and restructuring demand rose ~5% as higher interest rates pressure corporate balance sheets.
Macro-level drivers such as tightening credit conditions, rising regulatory enforcement, and accelerated adoption of cloud-based analytics are expected to sustain demand for FTI’s advisory portfolio.
For a deeper quantitative view of FCN’s valuation dynamics, you might explore the ValueRay platform’s analyst tools.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 266.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -9.61 > 1.0 |
| NWC/Revenue: 18.67% < 20% (prev 23.95%; Δ -5.27% < -1%) |
| CFO/TA 0.03 > 3% & CFO 107.7m > Net Income 266.1m |
| Net Debt (590.0m) to EBITDA (409.9m): 1.44 < 3 |
| Current Ratio: 1.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.9m) vs 12m ago -11.25% < -2% |
| Gross Margin: 31.95% > 18% (prev 0.33%; Δ 3162 % > 0.5%) |
| Asset Turnover: 105.4% > 50% (prev 106.0%; Δ -0.60% > 0%) |
| Interest Coverage Ratio: 24.75 > 6 (EBITDA TTM 409.9m / Interest Expense TTM 14.6m) |
Altman Z'' 4.80
| A: 0.20 (Total Current Assets 1.50b - Total Current Liabilities 809.0m) / Total Assets 3.49b |
| B: 0.54 (Retained Earnings 1.88b / Total Assets 3.49b) |
| C: 0.10 (EBIT TTM 360.7m / Avg Total Assets 3.50b) |
| D: 1.01 (Book Value of Equity 1.75b / Total Liabilities 1.74b) |
| Altman-Z'' Score: 4.80 = AA |
Beneish M -2.88
| DSRI: 1.01 (Receivables 1.23b/1.23b, Revenue 3.69b/3.73b) |
| GMI: 1.02 (GM 31.95% / 32.74%) |
| AQI: 1.13 (AQ_t 0.46 / AQ_t-1 0.41) |
| SGI: 0.99 (Revenue 3.69b / 3.73b) |
| TATA: 0.05 (NI 266.1m - CFO 107.7m) / TA 3.49b) |
| Beneish M-Score: -2.88 (Cap -4..+1) = A |
What is the price of FCN shares?
Over the past week, the price has changed by +2.44%, over one month by +0.71%, over three months by +9.12% and over the past year by -7.48%.
Is FCN a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FCN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 177.5 | -0.8% |
| Analysts Target Price | 177.5 | -0.8% |
| ValueRay Target Price | 180.8 | 1.1% |
FCN Fundamental Data Overview February 05, 2026
P/S = 1.5029
P/B = 3.0824
P/EG = 1.61
Revenue TTM = 3.69b USD
EBIT TTM = 360.7m USD
EBITDA TTM = 409.9m USD
Long Term Debt = 510.0m USD (from longTermDebt, last quarter)
Short Term Debt = 34.1m USD (from shortTermDebt, last fiscal year)
Debt = 736.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 590.0m USD (from netDebt column, last quarter)
Enterprise Value = 6.14b USD (5.55b + Debt 736.0m - CCE 146.0m)
Interest Coverage Ratio = 24.75 (Ebit TTM 360.7m / Interest Expense TTM 14.6m)
EV/FCF = 63.88x (Enterprise Value 6.14b / FCF TTM 96.1m)
FCF Yield = 1.57% (FCF TTM 96.1m / Enterprise Value 6.14b)
FCF Margin = 2.60% (FCF TTM 96.1m / Revenue TTM 3.69b)
Net Margin = 7.20% (Net Income TTM 266.1m / Revenue TTM 3.69b)
Gross Margin = 31.95% ((Revenue TTM 3.69b - Cost of Revenue TTM 2.51b) / Revenue TTM)
Gross Margin QoQ = 33.25% (prev 32.06%)
Tobins Q-Ratio = 1.76 (Enterprise Value 6.14b / Total Assets 3.49b)
Interest Expense / Debt = 1.04% (Interest Expense 7.63m / Debt 736.0m)
Taxrate = 25.88% (28.9m / 111.7m)
NOPAT = 267.4m (EBIT 360.7m * (1 - 25.88%))
Current Ratio = 1.85 (Total Current Assets 1.50b / Total Current Liabilities 809.0m)
Debt / Equity = 0.42 (Debt 736.0m / totalStockholderEquity, last quarter 1.75b)
Debt / EBITDA = 1.44 (Net Debt 590.0m / EBITDA 409.9m)
Debt / FCF = 6.14 (Net Debt 590.0m / FCF TTM 96.1m)
Total Stockholder Equity = 2.01b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.59% (Net Income 266.1m / Total Assets 3.49b)
RoE = 13.21% (Net Income TTM 266.1m / Total Stockholder Equity 2.01b)
RoCE = 14.29% (EBIT 360.7m / Capital Employed (Equity 2.01b + L.T.Debt 510.0m))
RoIC = 11.63% (NOPAT 267.4m / Invested Capital 2.30b)
WACC = 6.38% (E(5.55b)/V(6.29b) * Re(7.12%) + D(736.0m)/V(6.29b) * Rd(1.04%) * (1-Tc(0.26)))
Discount Rate = 7.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -5.64%
[DCF Debug] Terminal Value 81.64% ; FCFF base≈231.6m ; Y1≈187.0m ; Y5≈129.0m
Fair Price DCF = 92.11 (EV 3.43b - Net Debt 590.0m = Equity 2.84b / Shares 30.9m; r=6.38% [WACC]; 5y FCF grow -23.09% → 2.90% )
EPS Correlation: -12.46 | EPS CAGR: -44.89% | SUE: -4.0 | # QB: 0
Revenue Correlation: 90.49 | Revenue CAGR: 9.68% | SUE: 0.31 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.18 | Chg30d=+0.007 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=9.48 | Chg30d=+0.013 | Revisions Net=+1 | Growth EPS=+11.3% | Growth Revenue=+6.7%